Benutzer: Gast  Login
Titel:

[Intravitreal injection of bevacizumab for exsudative AMD with occult or minimal classic choroidal neovascularisation (CNV)]

Dokumenttyp:
Clinical Trial; English Abstract; Journal Article
Autor(en):
Maier, M; Feucht, N; Haas, K; Fiore, B; Winkler von Mohrenfels, C; Clos, A; Löhmann, C
Abstract:
PURPOSE: Systemic anti-VEGF therapy with bevacizumab was effective in neovascular AMD in the SANA study. Intravitreal bevacizumab has the advantage that a high concentration can be achieved in the eye with a low dose. First clinical studies showed a good therapeutic effect. METHODS: In a clinical study 93 patients with occult or minimal classic CNV due to neovascular AMD were treated with intravitreal injections of Bevacizumab (1.25 mg). Before, 1, 3 and 6 months after treatment visual acuity, i...     »
Zeitschriftentitel:
Klin Monatsbl Augenheilkd
Jahr:
2008
Band / Volume:
225
Heft / Issue:
9
Seitenangaben Beitrag:
818-24
Sprache:
de
Volltext / DOI:
doi:10.1055/s-2008-1027638
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/18759214
Print-ISSN:
0023-2165
TUM Einrichtung:
Klinik und Poliklinik für Augenheilkunde
 BibTeX